← Back to Analyst Consensus 
TMDX Buy
TransMedics Group, Inc.
Current Price —
Implied Upside —
Analysts 19
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 1 reiterations from 2 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 13, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Oct 7, 2026 | Barclays | initiate | — → Overweight | — | 53% |
| Sep 8, 2026 | TD Cowen | reiterate | Buy → Buy | — | 54% |
| Aug 5, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Aug 5, 2026 | Piper Sandler | reiterate | Overweight → Overweight | — | 54% |
| Aug 3, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Jul 28, 2026 | UBS | initiate | — → Neutral | — | 54% |
| Jul 6, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Jul 1, 2026 | TD Cowen | reiterate | Buy → Buy | — | 54% |
| Jun 30, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jun 18, 2026 | Stifel | maintain | Hold → Hold | — | 53% |
| May 26, 2026 | Stifel | maintain | Hold → Hold | — | 53% |
| May 6, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| May 6, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| May 6, 2026 | Stifel | maintain | Hold → Hold | — | 53% |
| May 6, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| May 6, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Apr 6, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Mar 9, 2026 | Stifel | maintain | Hold → Hold | — | 53% |
| Feb 25, 2026 | JP Morgan | maintain | Neutral → Neutral | $149 | 54% |
| Feb 25, 2026 | Oppenheimer | maintain | Outperform → Outperform | $175 | 52% |
| Feb 25, 2026 | Piper Sandler | maintain | Overweight → Overweight | $160 | 54% |
| Feb 25, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $170 | 58% |
| Feb 25, 2026 | Needham | maintain | Buy → Buy | $174 | 50% |
| Dec 17, 2025 | Canaccord Genuity | maintain | Buy → Buy | $148 | 48% |
| Dec 8, 2025 | Needham | maintain | Buy → Buy | $166 | 50% |
| Dec 2, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $135 | 54% |
| Oct 30, 2025 | Canaccord Genuity | maintain | Buy → Buy | $147 | 48% |
| Oct 30, 2025 | Piper Sandler | maintain | Overweight → Overweight | $140 | 54% |
| Oct 23, 2025 | Needham | upgrade | Hold → Buy | $148 | 50% |
| Oct 14, 2025 | Canaccord Genuity | maintain | Buy → Buy | $142 | 48% |
| Oct 13, 2025 | Jefferies | initiate | — → Buy | $145 | 52% |
| Sep 16, 2025 | Evercore ISI Group | initiate | — → Outperform | $155 | 58% |
| Sep 4, 2025 | Stifel | initiate | — → Hold | $115 | 53% |
| Aug 25, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Aug 1, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $123 | 54% |
| Jul 15, 2025 | Canaccord Genuity | maintain | Buy → Buy | $142 | 48% |
| Jun 17, 2025 | Oppenheimer | maintain | Outperform → Outperform | $150 | 52% |
| Jun 17, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Jun 4, 2025 | Piper Sandler | reiterate | Overweight → Overweight | $145 | 54% |
| Jun 3, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| May 9, 2025 | Oppenheimer | maintain | Outperform → Outperform | $130 | 52% |
| May 9, 2025 | Piper Sandler | reiterate | Overweight → Overweight | $125 | 54% |
| Apr 29, 2025 | Piper Sandler | reiterate | Overweight → Overweight | $105 | 54% |
| Apr 23, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Mar 26, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Mar 11, 2025 | Canaccord Genuity | maintain | Buy → Buy | $104 | 48% |
| Feb 5, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Dec 17, 2024 | JP Morgan | downgrade | Overweight → Neutral | $75 | 54% |
| Dec 11, 2024 | Piper Sandler | maintain | Overweight → Overweight | $90 | 54% |
Price Target Trend
May 22, 2026 Latest: $98.73 Oct 23, 2026
EPS Estimates
0q $0.29
Lo: $0.15 Hi: $0.40
10 analysts +1q $0.50
Lo: $0.31 Hi: $0.57
9 analysts 0y $1.51
Lo: $1.17 Hi: $1.63
10 analysts +1y $2.25
Lo: $1.61 Hi: $3.04
10 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days